Evaluation of Wild Bitter Melon () Extracts against Periodontopathic Bacteria ( and ) using Antibacterial, Anti-Inflammatory and Molecular Docking Analysis.

Wild bitter melon () extracts were prepared and their antibacterial and anti-biofilm assay were investigated against two different periodontopathic bacteria ( and ) for the first time to the best of our knowledge based on the presence of different phytochemical compounds. solvent extracts were prepared and phytochemical analysis was performed. Minimal inhibitory and bactericidal concentrations were determined. Antibacterial activity was evaluated using the standard well diffusion method. Anti-inflammatory studies on periodontal ligament (PDL) cell viability and lipopolysaccharide (LPS)-induced inflammation were performed. Molecular docking was investigated between the bioactive compound (Charantadiol A) of plant extract and biofilm-expressing genes in each test organism. Phytochemicals from ethanol extract showed promising results; alkaloids, flavonoids, phenols, and tannins were found present at considerable levels. The minimum inhibitory concentration was found to be 400 μg/mL for and . Antibacterial activity expressed in terms of zone of inhibition showed 14 mm to 18 mm zones against the test organisms. The molecular docking report revealed the maximum binding energy of about -6.54 Kcal/Mol of binding energy between Charantadiol A and fimA of . Anti-biofilm study showed that the minimum biofilm eradication concentration (MBEC) of expressed significantly good results against the test organisms. The PDL cell viability values expressed in percentage indicated the anti-inflammatory properties of extracts at three different known concentrations. The findings concluded that extracts have promising prospects as an anti-periodontopathic and anti-inflammatory agent.